Director / Editor: Victor Teboul, Ph.D.

Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

New Alzheimer’s drug aducanumab: what we know so far – and why more research is still needed

By Eleftheria Kodosaki, Research Associate in Neuroimmunology, Cardiff University
Aurora Veteleanu, PhD Candidate, Neuroscience, Cardiff University

The first drug targeting Alzheimer's disease has been approved in 20 years – but its approval isn't based on substantial evidence.

Read complete article

~	The denial of Palestinian childhood

~	Detoxifying masculinity: How men’s groups reshape attitudes

~	How marketing classes can rescue ‘ugly produce’ from becoming food waste

~	EU Misses Opportunity on Frontex Transparency, Accountability

~	Honoring a Philippine Human Rights Icon

~	Fallout: an expertly crafted TV adaptation that manages to incorporate some of the best elements of gameplay

~	Extraordinary Vietnam fraud case exposes the inherent vulnerabilities of banks

~	AI-powered ‘deep medicine’ could transform healthcare in the NHS and reconnect staff with their patients

~	Ukraine war: Putin’s plan to fire up Zaporizhzhia power plant risks massive nuclear disaster

~	How Israel continues to censor journalists covering the war in Gaza